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Abstract: - Type 2 Diabetes (T2D) is a metabolic disease characterized by abnormally high levels of sugar (glucose) in the blood 
(Hyperglycemia) which affects glucose homeostasis. It is caused due to the inability of the target cells to respond to insulin. 
Proteomics is the large-scale study of protein with their structures, functions, and information coded in a cell which is expressed 
and regulated at the protein level to achieve the function of an organism. Protein expression during the exposure of the cells to 
different glucose concentrations may alter and can give vital information about the pathogenesis of T2D. Study of underlying 
molecular mechanisms that lead to the development of T2D is important for the prevention and treatment of the disease the 
objective here is to study the effect of different glucose concentrations on proteomic profile of L6 cell lines. For this L6 skeletal 
muscle cells were exposed to different glucose (G) concentrations (0mM, and 25mM) for 48 hours. Total cell protein was extracted 
and protein profile was studied using SDS-PAGE. The identified proteins may provide information about disease pathophysiology 
and can serve as potential targets for therapeutic intervention of T2D.  
Key Words: — Type 2 Diabetes, Glucose homeostasis, Proteomic profile, Cell protein.    
I. INTRODUCTION 
The inability to properly utilize and/or store energy is the 
characteristic feature of metabolic disorders [1]. These may 
be inherited or acquired, the latter being more common and 
significant. Since these disorders affect the energy production 
or damage tissues critical for survival, these are clinically very 
important [2]. Diabetes is one of the most prominent 
metabolic disorders. 
Hyperglycemia is the condition of high blood sugar level [3]. 
People with diabetes are affected by this condition. After our 
meals, glucose in the blood increases which is why the 
hormone insulin is released from the pancreas [4]. It prompts 
the liver to process the metabolism of glucose which causes 
the sugar level in the blood to reduce to normal level [5]. 
Sugar level of the blood remains high in a diabetic person. 
There are three reasons to explain this [6]: 
 Insulin is not produced in proper quantity.  
 Insulin is not being made at all.  
 Insulin is not effective. 
 
Two of the most common types of diabetes are:- 
 Type-1 diabetes: - It is an autoimmune disease. In 
this disease the pancreas are not able to produce 
insulin as the immune system of the patient attacks 
them. 
 Type-2 diabetes: - It is a disease in which either the 
body resists insulin or there is a defect in the 
secretion of insulin. 
L6 cell line of the rat and C2C12 cell line of the mouse are the 
two cell lines which are used to study the effect of glucose’s 
high as well as low concentration [7]. In order for these cells 
to differentiate, once the cells become confluent, they are 
shifted from a media rich in serum to that of the media less 
rich [8]. Therefore, these cells differentiate from myoblasts to 
myotubes. To study the proliferation and differentiation of the 
muscle cells these myoblasts act as a good tool. Cultured 
myoblasts shows all the characteristics of muscle myogenesis 
which basically includes migration and proliferation, 
formation of myotubes and contraction [9]. Hence in this 
study we have used L-6 muscle cells to determine the glucose 
uptake activity of the cells and to identify the different 
proteins [9]. By studying the whole proteome we will be able 
to compare the expression of the protein in the normal and 
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diseased condition and thus will be able to understand the 
underlying mechanism of the disease that is Diabetes (type-2) 
[10]. 
II. METHODOLOGY 
A. Cell Culture 
Skeletal muscle cells of the rat (L6 cell line) were procured 
from NCCS, Pune, India. The maintenance and the growth of 
the cells were done in monolayer culture in Dulbecco's 
modified Eagle Medium (DMEM) supplemented with 10 % 
fetal bovine serum (FBS), 10mg ml-1 penicillin, 100mg ml-1 
streptomycin in a condition of 5% CO2 at 37°C until they 
become 80-90% confluent. 
B. Testing Of Cell Viability and Counting With the 
Help of Trypan Blue Exclusion 
To know the number of living cells present in the cell 
suspension, trypan blue test was done. The main principle of 
this method is that the live cells contain cell membranes that 
are intact and therefore can exclude dyes like trypan blue, 
propidium, etc. The dead cells do not have intact cell 
membranes [11].  When the dye is being mixed with the cell 
suspension, it will either take up the dye or will exclude the 
dye. After mixing, if we will examine the cell suspension 
under microscope, the living or viable cell will be having a 
clear cytoplasm but the nonviable one will be having blue 
cytoplasm [11]. 
C. Differentiation of L6 Myoblasts into Myotubes 
Rat L6 skeletal muscle cells were grown in DMEM 
supplemented with 10% FBS, 10µg ml-1 penicillin, 100 µg 
ml-1 streptomycin in the presence of 5% CO2 at 37°C until 
they become 80-90% confluent. For a 6 well tissue culture 
plate the seeding density is 0.3 × 105 cells per well. To trigger 
the differentiation of L6 myoblasts into myotubes, cells were 
cultured in glucose free DMEM (D-5030 Sigma Aldrich) 
containing 2% FBS (RM1112; Himedia) (differentiation 
medium, DM) for 7-8 days with medium change after 48 
hours. Within 25-37 hours of incubation, the fusion of 
myoblasts starts. After around 48 hours, small myotubes were 
clearly seen. After 72-96 hours the small myotubes become 
large as well as mature. 
The experiment was performed by inoculation of the cell 
suspension in six-well plate and incubated at 37°C for 24 
hours. The cells were exposed to DM containing different 




Cells were exposed to glucose free DM containing different 
glucose concentration for 48 hrs. The experiment was 
performed in triplicates. The seeding density per well in 6 well 
plate is 3 lakhs so the total cells needed per plate will be 18 
lakhs after confluence. For the counting of the cells the 
Trypan blue dye exclusion test was performed. 
D. Protein Extraction 
The cells were trypsinized and centrifuged at 1200 rpm for 
five minutes. The pellet obtained was washed with PBS and 
0.2 ml protein extraction buffer was added. The mixture was 
incubated on ice with tapping at every ten minutes. After one 
hour, centrifugation at 10,000 rpm was done for eighteen 
minutes at 4˚C. The supernatant was collected. 
E. Protein Estimation and SDS-PAGE 
Bradford assay is done to find out the total concentration of a 
protein in a sample. This method gives the measurement of 
the presence of the basic amino acid residues i.e. lysine, 
histidine and arginine since these contributes to the protein-
dye complex formation. Absorbance was taken at 595nm. 
coomassie. The concentration of a protein in a test sample is 
determined by comparing the result to that of a protein 
standard. As standard, different proteins can be used but the 
most common and widely used protein is Bovine Serum 
Albumin (BSA). Lastly SDS-PAGE was done. 
III. RESULTS 
A. Cell Culture 
2×105 cells were seeded in T-25 culture flask. After 72 hrs of 
seeding L6 cell lines showed confluency of about 90%. . 
 
Fig.1. Rat skeletal muscle cell lines 
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B. Differentiation of Myoblasts into Myotubes 
To differentiate myoblasts into myotubes cells were exposed 
to differentiation media containing 2% FBS for 7-8 days. 
 
Fig.2. L6 Cells after differentiation 
C. Protein extraction and estimation 
Total volume of protein extracted from L6 cells exposed to 
0mM and 25mM is represented in table.1. 
Table.1. Total volume of protein extracted from each sample 
Bradford assay is done to find out the total concentration of a 
protein in a sample. The concentration of a protein in a test 
sample is determined by comparing the result to that of a 
protein standard. BSA is been taken as a protein standard. 
Standard graph for BSA is shown in figure.3. 
 
Fig.3. BSA Standard curve 
The concentration of the protein was same in different 
samples after Bradford assay is represented in the following 
table 
Table.2. Protein concentration of different samples 
Protein concentration of cellular extracts was in the range of 
16.6-17.7 μg/μl. 
D. SDS-PAGE Result 
 
Fig.4. SDS-PAGE of total protein extract of the L6 cells exposed to 
different glucose concentration. (Lane 1: Medium range molecular 
marker, Lane 2: Control, Lane 3: 0mM, Lane 4: 25mM) 
IV. CONCLUSION AND DISCUSSION 
As proteins play relevant role in all biological functions 
proteomic analysis of different tissues gives useful 
information about the disease. Present work is aimed to study 
the proteomic profile of L6 cells exposed to different glucose 
concentrations. For this purpose L6 cells were cultured 
successfully. To study the effect of various glucose 
concentrations, L6 myoblast cells were serum starved (2% 
FBS) so that they can be converted into myotubes. Protein 
extraction and estimation was done and protein bands were 
observed after SDS-PAGE.  
A protein band with approximately 34 KDa molecular weight 
appeared in all the samples loaded in the gel. This protein may 
be Muscle ankyrin repeat protein. This is a transcriptional 
regulator which helps in the expression of the protein during 




















Sample Volume of extracted 
protein 
Control 200 µl 
0 Mm 200 µl 
25 Mm 200 µl 
 
Samples Concentration 
Control 16.6 μg/μl 
0Mm 17.1 μg/μl 
25Mm 17.7 μg/μl 
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recovery of the cell when they are starved. Since L6 cells were 
serum starved in order to initiate differentiation from 
myoblasts to myotubes that’s why this protein appeared in all 
three samples (Control, 0mM, 25mM). 
A protein band with approximately 28.8 KDa molecular 
weight appeared in Control lane and 0mM lane. This protein 
may be a protein called nebulin-013 which interacts to 
generate the mechanical force needed for muscle contraction 
[49]. Nebulin which plays important role in the regulation of 
muscle contraction is not present in 25mM lane. The absence 
of this protein is indicating that hyperglycemic condition is 
related with muscle contraction. 
A protein band with approximately 25 KDa molecular weight 
appeared in control lane and 0mM lane. This protein may be 
Troponin T3 which binds with Ca(2+) and initiates the 
process of muscle contraction. In diabetic condition (type-2) 
there is change in the skeletal muscle health particularly on 
the growth and repair capacity [50]. Absence of this protein 
band in 25mM lane indicates its role in hyperglycemic 
condition. 
A protein band with approximately 24 KDa molecular weight 
appeared in all the samples. This may be Caveolon-3 protein 
which plays a role in the sarcolemma repair mechanism of 
skeletal cells.  
A protein band with approximately 23 KDa molecular weight 
appeared in Control lane and 0mM lane. This may be 
Synaptosomal associated protein 23 (Snap 23) which is a 
protein expressed in human skeletal muscle. Its role is to 
mediate insulin-stimulated docking and fusion of GLUT-4 
cell with the plasma membrane. Since there is no insulin-
stimulated docking in the diseased cell, this protein band is 
absent from 25mM lane. 
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